dc.creator | Reis, Leonardo O | |
dc.creator | Fávaro, Wagner J | |
dc.creator | Ferreira, Ubirajara | |
dc.creator | Billis, Athanase | |
dc.creator | Fazuoli, Mariana G | |
dc.creator | Cagnon, Valéria H A | |
dc.date | 2010-Aug | |
dc.date | 2015-11-27T13:17:46Z | |
dc.date | 2015-11-27T13:17:46Z | |
dc.date.accessioned | 2018-03-29T01:10:42Z | |
dc.date.available | 2018-03-29T01:10:42Z | |
dc.identifier | World Journal Of Urology. v. 28, n. 4, p. 499-505, 2010-Aug. | |
dc.identifier | 1433-8726 | |
dc.identifier | 10.1007/s00345-010-0545-3 | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/20373103 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/198805 | |
dc.identifier | 20373103 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1299038 | |
dc.description | No optimal, well designed and reproducible animal model for upper urothelial carcinogenesis exists. This study characterized the histopathological features on top of immunolocalization of alpha-dystroglycans (alpha-DG) and matrix metalloproteinase (MMP-9) and cell turn-over in the upper urinary tract using a novel experimental model. Seventy-five female Fischer 344 rats were divided into three groups: the control group received a 0.30-ml dose of 0.9% physiological saline; the MNU group (chemical carcinogen N-methyl-N-nitrosourea) received 0.30 ml of MNU; and the MNU-citrate group received 0.30 ml of MNU plus sodium citrate, every one intravesically every other week for a total of 4 doses. After 15 weeks, bladder, ureters and renal pelvis were collected for morphological and molecular analysis. Associated management with MNU and sodium citrate was able to lead to 100% of both urinary bladder and upper urinary tract tumors, being the high-grade noninvasive papillary urothelial carcinoma the most frequent lesion. The upper urothelium showed reduced alpha-DG and increased MMP-9 and Ki-67 immunoreactivities in the MNU-citrate group in relation to the other groups. MNU group presented no upper urothelium tumor and 100% bladder tumor. This is a relevant evolution on experimental animal model for upper urinary tract carcinogenesis field. MMP-dependent disruption of the DG complex plays an important role in urothelial tumor carcinogenesis and showed the model applicability and significance. MNU-citrate model could contribute to a better understanding of human upper urothelial cancer development as well as to its local treatment strategies in a near future. | |
dc.description | 28 | |
dc.description | 499-505 | |
dc.language | eng | |
dc.relation | World Journal Of Urology | |
dc.relation | World J Urol | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Alkylating Agents | |
dc.subject | Animals | |
dc.subject | Biopsy | |
dc.subject | Citrates | |
dc.subject | Disease Models, Animal | |
dc.subject | Female | |
dc.subject | Kidney Medulla | |
dc.subject | Methylnitrosourea | |
dc.subject | Rats | |
dc.subject | Rats, Inbred F344 | |
dc.subject | Ureter | |
dc.subject | Urinary Bladder | |
dc.subject | Urography | |
dc.subject | Urologic Neoplasms | |
dc.subject | Urothelium | |
dc.title | Evolution On Experimental Animal Model For Upper Urothelium Carcinogenesis. | |
dc.type | Artículos de revistas | |